Skip to content

Docs (opens in a new tab)Pricing Ideas Benchmark

Sign in Sign up

F

FATE

FATE THERAPEUTICS INC

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$2.07

+1.23%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsIdeas

Idea

No published Drillr research on FATE yet.

Ask Drillr about FATE Browse research →

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Workspace|Docs (opens in a new tab)|Pricing|Research|Methodology|Privacy|Disclaimer|Contact|© 2026 LIL GREBE INC.